Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Nasdaq  -  04:00 2022-10-04 pm EDT
125.67 USD   +3.87%
01:18aModerna asks Japan health ministry to approve BA.5-tailored vaccine
AQ
12:24aEU Health Agency Grants Standard Nod to Moderna's COVID-19 Jab, Renews Conditional OK for Novavax Shot
MT
10/03Insider Sell: Moderna
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

US Public Health Agency Advisers Recommend Moderna's COVID-19 Jab For Ages Six to 17

06/24/2022 | 01:15am EDT


© MT Newswires 2022
All news about MODERNA, INC.
01:18aModerna asks Japan health ministry to approve BA.5-tailored vaccine
AQ
12:24aEU Health Agency Grants Standard Nod to Moderna's COVID-19 Jab, Renews Conditional OK f..
MT
10/03Insider Sell: Moderna
MT
10/03Mexico taps private sector again in effort to keep food prices down
RE
10/03Moderna Reportedly Refuses China's Request to Reveal COVID-19 Vaccine Technology
MT
10/03Moderna refuses request to hand over Covid-19 vaccine tech to China
AQ
10/02Moderna Rejects China's Request To Transfer COVID-19 Vaccine Technology Amid Safety Woe..
MT
10/01Moderna refused China request to reveal vaccine technology - FT
RE
09/30Insider Sell: Moderna
MT
09/30Two thirds of U.S. adults don't plan on getting COVID boosters soon - poll
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 21 836 M - -
Net income 2022 10 884 M - -
Net cash 2022 16 503 M - -
P/E ratio 2022 4,81x
Yield 2022 -
Capitalization 49 162 M 49 162 M -
EV / Sales 2022 1,50x
EV / Sales 2023 2,87x
Nbr of Employees 2 700
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 125,67 $
Average target price 218,07 $
Spread / Average Target 73,5%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
James M. Mock Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-50.52%49 162
LONZA GROUP AG-35.56%36 715
IQVIA HOLDINGS INC.-31.56%34 728
SEAGEN INC.-9.98%25 397
ALNYLAM PHARMACEUTICALS, INC.16.05%23 620
CELLTRION, INC.-12.63%16 854